Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Amortizatization of Intangibles: 2023-2024

Historic Amortizatization of Intangibles for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $5.0 million.

  • CG Oncology's Amortizatization of Intangibles fell 112.71% to -$201,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $710,000, marking a year-over-year decrease of 90.79%. This contributed to the annual value of $5.0 million for FY2024, which is 73.63% up from last year.
  • CG Oncology's Amortizatization of Intangibles amounted to $5.0 million in FY2024, which was up 73.63% from $2.9 million recorded in FY2023.
  • In the past 5 years, CG Oncology's Amortizatization of Intangibles registered a high of $5.0 million during FY2024, and its lowest value of $2.9 million during FY2023.
  • Over the past 2 years, CG Oncology's median Amortizatization of Intangibles value was $3.9 million (recorded in 2023), while the average stood at $3.9 million.
  • Data for CG Oncology's Amortizatization of Intangibles shows a peak YoY surged of 73.63% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Amortizatization of Intangibles stood at $2.9 million in 2023, then spiked by 73.63% to $5.0 million in 2024.